ENUM .0065 Huge Read Currently, Enumeral has completed four collaborations with leading pharmaceutical companies (Sanofi (NYSE:SNY), Crucell (NASDAQ:CRXL), Celgene (NASDAQ:CELG) and Novartis (NYSE:NVS)) and established proof-of-concept data which provided modest cash payments (in the hundreds of thousands of dollars per project). Some of these collaborations have led to additional discussions regarding expanded programs